Using the Mirena Coil as Part of HRT in Perimenopause
How the Mirena IUS works as the progestogen component of HRT in perimenopause. Covers combination with patches and gel, advantages, and who it suits best.
What Is the Mirena and How Does It Work?
The Mirena is a hormone-releasing intrauterine system (IUS) that sits inside the uterus and releases a small daily dose of levonorgestrel, a synthetic progestogen, directly into the uterine cavity. It is primarily known as a contraceptive device, but it has a second, clinically important use: providing the progestogen component of combined HRT for women who have a uterus and are using systemic oestrogen therapy. The Mirena releases approximately 20 micrograms of levonorgestrel per day initially, decreasing gradually over its five-year life. Because it delivers hormone directly into the uterus, it achieves high local concentrations in the endometrium with very low blood levels. This localised action is the key to understanding why so many women find the Mirena preferable to oral or transdermal progestogens. The endometrium receives enough progestogen to remain inactive and protected from the stimulating effects of oestrogen, while the rest of the body is exposed to only a fraction of the hormone. In contrast to oral synthetic progestogens taken daily or cyclically, the Mirena operates silently in the background, requiring no daily pills, no timing decisions, and no monthly progestogen phase.
Using the Mirena Alongside Oestrogen: How the Combination Works
For women who want to use systemic oestrogen, whether as a patch, gel, or spray, but have a uterus that requires endometrial protection, the Mirena can replace the need for any additional progestogen tablet or patch component. The oestrogen is applied externally in the usual way, and the Mirena handles the progestogen part. This means a woman can choose her oestrogen dose and formulation entirely independently, without it being constrained by what combined patch is available. This flexibility is clinically valuable: oestrogen can be titrated up or down in small increments using a gel or spray without needing to adjust the progestogen element. For women who are also still perimenopausal and want contraception, this combination is particularly elegant because the Mirena provides both progestogen cover for HRT and reliable pregnancy prevention in a single device. Common oestrogen preparations used alongside the Mirena include Oestrogel, Sandrena, Lenzetto spray, or patches such as Evorel or Estradot. There is no preference between these from a Mirena-compatibility standpoint. The combination is supported by NICE guidelines and is used routinely by many menopause specialists.
Advantages Over Oral and Transdermal Progestogens
The Mirena offers several meaningful advantages over oral progestogens for women who have significant progestogen sensitivity. Because blood levels of levonorgestrel from the Mirena are very low, systemic progestogen side effects such as mood changes, bloating, breast tenderness, headaches, and fatigue are substantially reduced or eliminated. Women who have struggled with oral norethisterone, medroxyprogesterone acetate, or even micronised progesterone frequently find the Mirena a transformative change. Beyond side effects, the Mirena eliminates the monthly progestogen phase pattern of sequential HRT, where women experience a predictable deterioration in mood and physical symptoms for 12 to 14 days per month. With the Mirena, oestrogen is used continuously, producing a more stable hormonal environment throughout the month. The Mirena also reliably suppresses menstruation in most women over time: irregular spotting is common in the first three to six months after insertion, but by one year approximately 50 percent of users have no bleeding at all, and by two years the proportion is higher still. For women troubled by heavy, irregular perimenopausal periods, this is an additional benefit beyond the HRT context. On the safety side, the Mirena may carry a lower breast cancer risk than higher-dose synthetic progestogens, though this question continues to be studied.
Who Is Best Suited to the Mirena in a HRT Context?
The Mirena within a HRT regimen is particularly well suited to certain groups of women. Women who have experienced significant progestogen-related side effects with oral or patch-based progestogens, including mood disturbance, bloating, or worsening of existing mental health conditions during the progestogen phase, are ideal candidates. Women in perimenopause who still need reliable contraception gain a dual-purpose device that addresses both needs simultaneously, avoiding the need for separate contraceptive and HRT management. Women with heavy or irregular perimenopausal menstrual bleeding may find the Mirena manages their periods and enables HRT in a single intervention. Women who would struggle with the compliance demands of a daily or twice-daily oral progestogen, whether due to shift work, busy schedules, or memory challenges related to brain fog, benefit from the set-and-forget nature of an IUS. The Mirena is less ideal for women who are approaching the very end of their fertile years and simply need a short-term progestogen bridge, or for women who have contraindications to an IUS such as unexplained uterine cavity distortion, active uterine infection, or certain uterine abnormalities. A GP or gynaecologist will assess suitability before insertion.
Insertion, the Adjustment Period, and Managing Irregular Bleeding
Mirena insertion is carried out by a trained GP, practice nurse, or gynaecologist and takes around five to ten minutes. It can be uncomfortable, particularly for women who have not had a vaginal delivery. A local anaesthetic is not routinely used in most UK clinics, though some offer it. Women who are anxious about insertion can request a referral to a unit that offers cervical anaesthesia or topical local anaesthetic. Taking an over-the-counter painkiller 30 to 60 minutes before the appointment can reduce procedural discomfort. After insertion, cramping can persist for a few hours to a day, and some spotting is normal. The adjustment period for the Mirena in a HRT context is typically three to six months. Irregular spotting, light bleeding, or unpredictable light periods are expected during this time and are not a sign of treatment failure. It is important to set this expectation clearly before insertion, as many women are caught off guard by spotting when they expected the Mirena to suppress bleeding immediately. By six months most women see significantly reduced or absent bleeding. Any heavy or prolonged bleeding after the initial adjustment period warrants GP review to check that the coil is correctly positioned and to rule out other causes.
Duration, Replacement and Long-Term Considerations
The Mirena is licensed for five years for contraception and for five years as the progestogen component of HRT. Some clinical guidance and emerging evidence supports extended use of up to seven years for the endometrial protection indication in women who are using it solely within a HRT regimen and who are post-menopausal, though this is off-label and should be discussed with a prescriber. When a Mirena reaches the end of its recommended duration, it needs to be replaced if the woman is continuing HRT. Replacement is similar to the initial insertion and carries the same procedural considerations. For perimenopausal women using the Mirena for contraception as well as HRT, NICE recommends continuing the Mirena for contraceptive purposes until age 55, as the risk of natural pregnancy after that age is vanishingly small. After age 55, the Mirena can continue as the progestogen component of HRT even if contraception is no longer the priority. Women who are post-menopausal and have confirmed no periods for 12 months can use the Mirena continuously until it needs replacing, with no requirement for periodic progestogen challenges or additional cycling. This simplicity is a significant practical advantage for long-term HRT management.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.